Orison Corporation was founded to design, manufacture and market a proprietary ultrasound technology platform for early breast cancer detection and diagnosis.

Orison’s technology utilizes Full Field Digital Ultrasound (FDDU) as an enabler that allows the radiologist, for the first time, to view breast tissue in a three dimensional environment. The outcome is earlier detection of breast cancer prior to metastasis, resulting in greater five-year survival rates and decreased treatment costs.

 

For more information contact:

David Crockett

423-282-5919